{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:28:04Z","timestamp":1792114084987,"version":"4.4.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Appropriate dialysis prescription in the transitional setting from chronic kidney disease to end-stage kidney disease is still challenging. Conventional thrice-weekly haemodialysis (HD) might be associated with rapid loss of residual kidney function (RKF) and high mortality. The benefits and risks of incremental HD compared with conventional HD were explored in this systematic review and meta-analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We searched MEDLINE, Scopus and Cochrane Central Register of Controlled Trials up to April 2023 for studies that compared the impacts of incremental (once- or twice-weekly HD) and conventional thrice-weekly HD on cardiovascular events, RKF, vascular access complications, quality of life, hospitalization and mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 36 articles (138\u00a0939 participants) were included in this meta-analysis. The mortality rate and cardiovascular events were similar between incremental and conventional HD {odds ratio [OR] 0.87 [95% confidence interval (CI)] 0.72\u20131.04 and OR 0.67 [95% CI 0.43\u20131.05], respectively}. However, hospitalization and loss of RKF were significantly lower in patients treated with incremental HD [OR 0.44 (95% CI 0.27\u20130.72) and OR 0.31 (95% CI 0.25\u20130.39), respectively]. In a sensitivity analysis that included studies restricted to those with RKF or urine output criteria, incremental HD had significantly lower cardiovascular events [OR 0.22 (95% CI 0.08\u20130.63)] and mortality [OR 0.54 (95% CI 0.37\u20130.79)]. Vascular access complications, hyperkalaemia and volume overload were not statistically different between groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Incremental HD has been shown to be safe and may provide superior benefits in clinical outcomes, particularly in appropriately selected patients. Large-scale randomized controlled trials are required to confirm these potential advantages.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfad280","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:52:53Z","timestamp":1699617173000},"source":"Crossref","is-referenced-by-count":29,"title":["Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6236-8893","authenticated-orcid":false,"given":"Kullaya","family":"Takkavatakarn","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Jintanapramote","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Bhumibol Adulyadej Hospital , Royal Thai Air Force, Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeerath","family":"Phannajit","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand"},{"name":"Research Unit for Metabolic Bone Disease in CKD patients, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kearkiat","family":"Praditpornsilpa","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Eiam-Ong","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paweena","family":"Susantitaphong","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand"},{"name":"Research Unit for Metabolic Bone Disease in CKD patients, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"2024010516000556300_bib1","volume-title":"2020 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","author":"United States Renal Data System","year":"2020"},{"key":"2024010516000556300_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.2013.252","article-title":"Worldwide, mortality risk is high soon after initiation of hemodialysis","volume":"85","author":"Robinson","year":"2014","journal-title":"Kidney Int"},{"key":"2024010516000556300_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2215\/CJN.00330117","article-title":"Preservation of residual kidney function and urine volume in patients on dialysis","volume":"12","author":"Krediet","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024010516000556300_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ekir.2019.11.014","article-title":"Narrative review of incremental hemodialysis","volume":"5","author":"Murea","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2024010516000556300_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"2024010516000556300_bib6","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2024010516000556300_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"2024010516000556300_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2024010516000556300_bib9","first-page":"2022","article-title":"Could incremental haemodialysis be a new standard of care? A suggestion from a long-term observational study","volume":"39","author":"Casino","year":"2022","journal-title":"G Ital Nefrol"},{"key":"2024010516000556300_bib10","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1093\/ndt\/gfac205","article-title":"Outcomes of incident patients treated with incremental haemodialysis as compared to standard haemodialysis and peritoneal dialysis","volume":"37","author":"Jaques","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2024010516000556300_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12882-022-02946-w","article-title":"Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis","volume":"23","author":"Murea","year":"2022","journal-title":"BMC Nephrol"},{"key":"2024010516000556300_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.ajkd.2021.12.001","article-title":"Twice-weekly hemodialysis with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis: a pilot study","volume":"80","author":"Murea","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2024010516000556300_bib13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.21608\/ejhm.2022.231634","article-title":"Incremental versus conventional hemodialysis: which is better for prevalent hemodialysis patients?","volume":"87","author":"Ahmed","year":"2022","journal-title":"Egypt J Hosp Med"},{"key":"2024010516000556300_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ekir.2022.02.010","article-title":"Incremental and personalized hemodialysis start: a new standard of care","volume":"7","author":"Torreggiani","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2024010516000556300_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.kint.2021.07.025","article-title":"A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function","volume":"101","author":"Vilar","year":"2022","journal-title":"Kidney Int"},{"key":"2024010516000556300_bib16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2147\/TCRM.S332218","article-title":"Benefits of incremental hemodialysis seen in a historical cohort study","volume":"17","author":"Chen","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"2024010516000556300_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11255-020-02697-3","article-title":"Comparison of nutritional and hydration status in patients undergoing twice and thrice-weekly hemodialysis: a silent drama in developing countries","volume":"53","author":"Nieves-Anaya","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"2024010516000556300_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.11604\/pamj.2020.35.129.20285","article-title":"Twice weekly hemodialysis is safe at the beginning of kidney replacement therapy: the experience of the Nephrology Department at Hedi Chaker University Hospital, Sfax, south of Tunisia","volume":"35","author":"Chaker","year":"2020","journal-title":"Pan Afr Med J"},{"key":"2024010516000556300_bib19","doi-asserted-by":"crossref","first-page":"e20202","DOI":"10.1097\/MD.0000000000020202","article-title":"Impact of twice- or three-times-weekly maintenance hemodialysis on patient outcomes: a multicenter randomized trial","volume":"99","author":"Dai","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2024010516000556300_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/hdi.12743","article-title":"Comparison of characteristics of centers practicing incremental vs. conventional approaches to hemodialysis delivery \u2013 postdialysis recovery time and patient survival","volume":"23","author":"Davenport","year":"2019","journal-title":"Hemodial Int"},{"key":"2024010516000556300_bib21","first-page":"S39","article-title":"Comparison of mortality and other clinical outcomes based on frequency of hemodialysis in a large, national, dialysis cohort","volume":"29","author":"Kamal","year":"2019","journal-title":"Indian J Nephrol"},{"key":"2024010516000556300_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/ndt\/gfy321","article-title":"Initiating haemodialysis twice-weekly as part of an incremental programme may protect residual kidney function","volume":"34","author":"Kaja Kamal","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2024010516000556300_bib23","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/nep.13556","article-title":"Incremental and twice weekly haemodialysis in Australia and New Zealand","volume":"24","author":"Wolley","year":"2019","journal-title":"Nephrology"},{"key":"2024010516000556300_bib24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1159\/000491566","article-title":"Clinical outcome of twice-weekly hemodialysis patients with long-term dialysis vintage","volume":"43","author":"Lin","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"2024010516000556300_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ekir.2018.03.008","article-title":"Twice-weekly hemodialysis and clinical outcomes in the China dialysis outcomes and practice patterns study","volume":"3","author":"Yan","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2024010516000556300_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/0971-4065.202844","article-title":"A comparison of practice pattern and outcome of twice-weekly and thrice-weekly hemodialysis patients","volume":"27","author":"Mukherjee","year":"2017","journal-title":"Indian J Nephrol"},{"key":"2024010516000556300_bib27","first-page":"355","article-title":"Comparison of outcomes between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea","volume":"32","author":"Park","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2024010516000556300_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.jrn.2016.07.001","article-title":"Concurrence of serum creatinine and albumin with lower risk for death in twice-weekly hemodialysis patients","volume":"27","author":"Wang","year":"2017","journal-title":"J Ren Nutr"},{"key":"2024010516000556300_bib29","doi-asserted-by":"crossref","first-page":"e2767","DOI":"10.1097\/MD.0000000000002767","article-title":"Comparison of clinical outcome between twice-weekly and thrice-weekly hemodialysis in patients with residual kidney function","volume":"95","author":"Hwang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2024010516000556300_bib30","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.kint.2016.05.028","article-title":"Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis","volume":"90","author":"Mathew","year":"2016","journal-title":"Kidney Int"},{"key":"2024010516000556300_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/j.ajkd.2016.01.008","article-title":"Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study","volume":"68","author":"Obi","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2024010516000556300_bib32","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/ndt\/gft472","article-title":"Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study","volume":"29","author":"Bieber","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2024010516000556300_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-2369-15-172","article-title":"The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients","volume":"15","author":"Caria","year":"2014","journal-title":"BMC Nephrol"},{"key":"2024010516000556300_bib34","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijcard.2014.04.052","article-title":"Risk of cardiovascular disease in patients on thrice-weekly versus twice-weekly hemodialysis","volume":"174","author":"Cheng","year":"2014","journal-title":"Int J Cardiol"},{"key":"2024010516000556300_bib35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijcard.2014.04.140","article-title":"Risk of intradialytic hypotension in patients on thrice-weekly versus twice-weekly hemodialysis","volume":"174","author":"Lei","year":"2014","journal-title":"Int J Cardiol"},{"key":"2024010516000556300_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000368885","article-title":"Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study","volume":"38","author":"Panaput","year":"2014","journal-title":"Blood Purif"},{"key":"2024010516000556300_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000365819","article-title":"Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients","volume":"40","author":"Zhang","year":"2014","journal-title":"Am J Nephrol"},{"key":"2024010516000556300_bib38","first-page":"640","article-title":"Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis","volume":"33","author":"Teruel-Briones","year":"2013","journal-title":"Nefrologia"},{"key":"2024010516000556300_bib39","first-page":"767","article-title":"Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen","volume":"32","author":"Fern\u00e1ndez-Lucas","year":"2012","journal-title":"Nefrologia"},{"key":"2024010516000556300_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000334634","article-title":"Clinical outcome of twice-weekly hemodialysis patients in Shanghai","volume":"33","author":"Lin","year":"2012","journal-title":"Blood Purif"},{"key":"2024010516000556300_bib41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3390\/medicina46080074","article-title":"Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998\u20132005","volume":"46","author":"Stankuvien\u0117","year":"2010","journal-title":"Medicina (Kaunas)"},{"key":"2024010516000556300_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1440-1797.2008.01016.x","article-title":"Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis","volume":"14","author":"Lin","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"2024010516000556300_bib43","first-page":"624","article-title":"Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt\/V &gt;3.6","volume":"92","author":"Supasyndh","year":"2009","journal-title":"J Med Assoc Thai"},{"key":"2024010516000556300_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1159\/000013533","article-title":"Prescription of twice-weekly hemodialysis in the USA","volume":"19","author":"Hanson","year":"1999","journal-title":"Am J Nephrol"},{"key":"2024010516000556300_bib45","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/nep.13252","article-title":"Comparison between incremental and thrice-weekly haemodialysis: systematic review and meta-analysis","volume":"24","author":"Liu","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"2024010516000556300_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ndt\/gfac274","article-title":"Impact of incremental initiation of haemodialysis on mortality: a systematic review and meta-analysis","volume":"38","author":"Caton","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2024010516000556300_bib47","first-page":"884","article-title":"KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update","volume-title":"Am J Kidney Dis","author":"National Kidney Foundation","year":"2015"},{"key":"2024010516000556300_bib48","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/nep.13427","article-title":"The importance of residual kidney function in haemodialysis patients","volume":"23","author":"Kong","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"2024010516000556300_bib49","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/03913988211049815","article-title":"The role of once-weekly online hemodiafiltration with low protein diet for initiation of renal replacement therapy: a case series","volume":"44","author":"Takkavatakarn","year":"2021","journal-title":"Int J Artif Organs"},{"key":"2024010516000556300_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.ajkd.2014.07.034","article-title":"Once-weekly hemodialysis: a single-center experience","volume":"65","author":"Libetta","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2024010516000556300_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2021.01.018","article-title":"Association of beta-2-microglobulin and cardiovascular events and mortality: a systematic review and meta-analysis","volume":"320","author":"Shi","year":"2021","journal-title":"Atherosclerosis"},{"key":"2024010516000556300_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IJNRD.S286947","article-title":"Incremental hemodialysis: what we know so far","volume":"15","author":"Soi","year":"2022","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"2024010516000556300_bib53","article-title":"Individualized incremental hemodialysis study (IIHD)","author":"Alexandria University"},{"key":"2024010516000556300_bib54","article-title":"Effects of low protein diet supplemented with ketoanalogues on preservation of kidney function in incremental dialysis","author":"Chulalongkorn University"},{"key":"2024010516000556300_bib55","article-title":"Incremental haemodialysis in incident patients","author":"Fundaci\u00f3n para la Formaci\u00f3n e Investigaci\u00f3n de los Profesionales de la Salud de Extremadura"},{"key":"2024010516000556300_bib56","article-title":"Incremental Hemodialysis: the TwoPlus Trial","author":"Wake Forest University Health Sciences"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfad280\/54329681\/sfad280.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/1\/sfad280\/55106170\/sfad280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/1\/sfad280\/55106170\/sfad280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T16:02:09Z","timestamp":1704470529000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfad280\/7382238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,11,8]]},"published-print":{"date-parts":[[2024,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfad280","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,11,8]]},"article-number":"sfad280"}}